Drug interactions between ferrous gluconate and Synthroid
| Results for the following 2 drugs: |
|---|
| ferrous gluconate |
| Synthroid (levothyroxine) |
Interactions between your selected drugs
levothyroxine ↔ ferrous gluconate
Applies to:Synthroid (levothyroxine) and ferrous gluconate
ADJUST DOSING INTERVAL: Concurrent administration of iron-containing products may decrease the oral bioavailability and pharmacologic effects of levothyroxine. The exact mechanism of interaction is unknown, but in vitro data suggest it may involve nonspecific adsorption of levothyroxine to iron at acidic pH levels, resulting in an insoluble complex that is poorly absorbed from the gastrointestinal tract. In one study, 14 patients with hypothyroidism who were taking a stable long-term regimen of levothyroxine demonstrated an increase in mean serum thyrotropin (thyroid-stimulating hormone, or TSH) level from 1.6 to 5.4 mU/L following the addition of ferrous sulfate (300 mg administered simultaneously with levothyroxine 30 to 60 minutes before breakfast) for 3 months. A total of 11 patients had increases in serum TSH at week 12 compared to baseline, including two that had levels above the upper limit of normal for the assay, indicating the presence of hypothyroidism. Nine of the eleven also had an increase in signs and symptoms of hypothyroidism based on subjective evaluation using a clinical score. It is not known whether this interaction occurs with other thyroid hormone preparations.
MANAGEMENT: Some experts recommend separating the times of administration of levothyroxine and iron-containing preparations by at least 2 to 4 hours. Monitoring of serum TSH levels is recommended. Patients with gastrointestinal or malabsorption disorders may be at a greater risk of developing clinical or subclinical hypothyroidism due to this interaction.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
